Fortress Biotech, Inc. (FBIO)
USD 1.77
(-2.75%)
USD 1.77
(-2.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -128.22 Million | -179.4 Million | -116.54 Million | -83.68 Million | -94.96 Million | -98.84 Million |
| Net Income | -60.63 Million | -213.91 Million | -164.82 Million | -102.98 Million | -101.66 Million | -130.8 Million |
| Depreciation & Amortization | 8.07 Million | 9.35 Million | 6.79 Million | 5.32 Million | 4.65 Million | 2.05 Million |
| Deferred income taxes | 7.87 Million | - | -38.79 Million | -5.18 Million | -18.34 Million | 287 Thousand |
| Stock-based compensation | 17.02 Million | 22.98 Million | 19.48 Million | 13.45 Million | 13.18 Million | 15.01 Million |
| Change in working capital | -12.51 Million | -715 Thousand | 36.37 Million | -4.78 Million | -4.84 Million | 5.73 Million |
| Other non-cash items | -88.05 Million | 2.88 Million | 24.43 Million | 10.48 Million | 12.04 Million | 8.85 Million |
| Investing Cash Flow | -2.1 Million | -22.92 Million | 40.51 Million | -7.16 Million | 20.09 Million | 18.82 Million |
| Investments in PPE | -8.09 Million | -3.05 Million | -16.34 Million | -7.16 Million | -9.39 Million | -9.35 Million |
| Acquisitions | 6 Million | -20 Million | 56.86 Million | - | -1.2 Million | 2.27 Million |
| Investment purchases | - | - | - | - | -5 Million | -52.6 Million |
| Sales/Maturities of investments | - | - | - | - | 22.6 Million | 71 Million |
| Other Investing Activities | -5000.00 | 127 Thousand | 45.08 Million | -5.23 Million | 13.08 Million | 7.5 Million |
| Financing Cash Flow | 32.73 Million | 75.31 Million | 148.99 Million | 172.41 Million | 146.71 Million | 50.64 Million |
| Debt repayment | -39.79 Million | -2.86 Million | -15.75 Million | -89.67 Million | -21.87 Million | -17.29 Million |
| Dividends payments | -8.76 Million | -8.78 Million | -8.78 Million | -6.75 Million | -2.55 Million | -2.34 Million |
| Common Stock Repurchased | -400 Thousand | -1.19 Million | - | -70 Thousand | -24 Thousand | -234 Thousand |
| Common Stock Issuance | 81.7 Million | 40.43 Million | 172.8 Million | 178.06 Million | 137.5 Million | 37.96 Million |
| Other Financing Activities | -1.08 Million | 47.72 Million | 172.77 Million | 90.84 Million | 33.66 Million | 35.69 Million |
| Accounts receivables | 12.52 Million | -5.38 Million | 768 Thousand | -5.85 Million | -8.14 Million | 2.26 Million |
| Accounts payables | -24.38 Million | 8.34 Million | 43.3 Million | 6.52 Million | 1.94 Million | 4.66 Million |
| Inventory | 3.95 Million | 1.74 Million | -8.45 Million | -547 Thousand | -179 Thousand | -507 Thousand |
| Other working capital | -4.61 Million | -5.42 Million | 756 Thousand | -4.89 Million | 1.53 Million | -680 Thousand |
| Cash at beginning of period | 178.26 Million | 307.96 Million | 234.99 Million | 153.43 Million | 81.58 Million | 110.95 Million |
| Cash at end of period | 80.92 Million | 180.95 Million | 307.96 Million | 234.99 Million | 153.43 Million | 81.58 Million |
| Capital Expenditure | -8.09 Million | -3.05 Million | -16.34 Million | -7.16 Million | -9.39 Million | -9.35 Million |
| Effect of forex changes on cash | -33 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -97.33 Million | -127.01 Million | 72.96 Million | 81.56 Million | 71.85 Million | -29.37 Million |
| Free Cash Flow | -136.32 Million | -182.45 Million | -132.88 Million | -90.84 Million | -104.35 Million | -108.2 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.94 Million | -15.41 Million | -9.27 Million | -60.63 Million | -10.72 Million | -59.3 Million |
| Depreciation & Amortization | 2.56 Million | 1.71 Million | 1.7 Million | 8.07 Million | 2.75 Million | 1.17 Million |
| Deferred income taxes | - | - | -20.84 Million | 7.87 Million | -4.99 Million | 10.04 Million |
| Stock-based compensation | 4.99 Million | 4.85 Million | 3.7 Million | 17.02 Million | 4.37 Million | 4.21 Million |
| Change in working capital | -3.19 Million | 5.66 Million | -18.15 Million | -12.51 Million | -8.26 Million | 7.75 Million |
| Other non-cash items | 191 Thousand | -21.47 Million | 7.93 Million | -88.05 Million | 76 Thousand | 2.81 Million |
| Investing Cash Flow | - | - | -63 Thousand | -2.1 Million | 4.99 Million | -2.03 Million |
| Investments in PPE | - | - | -63 Thousand | -8.09 Million | -1 Million | -34 Thousand |
| Acquisitions | - | - | -5.99 Million | 6 Million | 6 Million | 4.99 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -35 Thousand | -5000.00 | 5 Million | -7 Million |
| Financing Cash Flow | 14.26 Million | 27.85 Million | 43.61 Million | 32.73 Million | -2.68 Million | -30.38 Million |
| Debt repayment | -5 Million | - | -14.62 Million | -39.79 Million | -10 Million | -43.46 Million |
| Dividends payments | -2.18 Million | -2.18 Million | -2.18 Million | -8.76 Million | -2.19 Million | -2.19 Million |
| Common Stock Repurchased | -2.61 Million | - | -400 Thousand | -400 Thousand | 90 Thousand | 88 Thousand |
| Common Stock Issuance | 11.41 Million | 30.04 Million | 31.58 Million | 81.7 Million | 10.39 Million | 15.19 Million |
| Other Financing Activities | 30 Thousand | 29.86 Million | 97 Thousand | -1.08 Million | -979 Thousand | -5000.00 |
| Accounts receivables | -712 Thousand | 5.26 Million | -7.17 Million | 12.52 Million | 8.83 Million | 10.43 Million |
| Accounts payables | -5.5 Million | 2.66 Million | -7.36 Million | -24.38 Million | -17.45 Million | -4.34 Million |
| Inventory | 893 Thousand | -374 Thousand | 818 Thousand | 3.95 Million | 1.14 Million | 1.11 Million |
| Other working capital | 2.16 Million | -1.88 Million | -4.42 Million | -4.61 Million | -784 Thousand | 549 Thousand |
| Cash at beginning of period | 85.83 Million | 80.92 Million | 74.74 Million | 178.26 Million | 89.21 Million | 154.92 Million |
| Cash at end of period | 76.2 Million | 85.83 Million | 80.92 Million | 80.92 Million | 74.74 Million | 89.21 Million |
| Capital Expenditure | - | - | -63 Thousand | -8.09 Million | -1 Million | -34 Thousand |
| Effect of forex changes on cash | - | - | -2.43 Million | -33 Million | - | - |
| Net cash flow / Change in cash | -9.63 Million | 4.91 Million | 6.18 Million | -97.33 Million | -14.46 Million | -65.71 Million |
| Free Cash Flow | -21.83 Million | -25.38 Million | -34.99 Million | -136.32 Million | -17.78 Million | -33.32 Million |
003160
RPYTF
SME
0IC7
CBGPY
EUREKAFORBE